Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Electronic City Indonesia Tbk. (ECII) vs Merck Tbk. (MERK) Price & Performance

Electronic City Indonesia Tbk.Trade
Merck Tbk.Trade

Price performance (Past 24H)

Key statistics

Electronic City Indonesia Tbk. vs Merck Tbk. — how do they compare? Electronic City Indonesia Tbk. trades at Rp153 (market cap 202.82B, 1.54M 24h volume), while Merck Tbk. trades at Rp3,890 (market cap 1.75T, 29.1K 24h volume). The key difference: Merck Tbk. is far larger — about 8.6× Electronic City Indonesia Tbk.'s market cap, and Electronic City Indonesia Tbk. is more actively traded (1.54M versus 29.1K). Which is the better fit depends on your goals.

ECIIMERK
Market Cap
202.82B1.75T
Volume
1.54M29.1K
Lot
15.38K291
Turnover
237.9M113.37M
Average Price
154.663,895.98
Value
237.9M113.37M
Indicative Equilibrium Price
1533,890
Indicative Equilibrium Volume
251

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

ECII
View details
MERK
View details

About Electronic City Indonesia Tbk.

PT Electronic City Indonesia Tbk was establised on April 29, 2002. Electronic City manages a growing network that comprises 36 stores and 8 warehouses, with 39,706 sqm or gross selling area and 10,660 sqm of warehouse area (as of June 3, 2013). Electronic City implements a dual-branding strategy through the two types of its stores, namely Electronic City and Electronic City Outlet.

Read more on ECII

About Merck Tbk.

PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.

Read more on MERK